NanoViricides Inc. (NNVC)

[changes_iv]

Your inference from the excerpt directly contradicts the excerpt published on marketwatch.com Aug 19, 2013...

The Company has also started sub-kg scale production of our injectable FluCide(TM) anti-influenza drug candidate at its current facility. Safety and toxicology studies of our injectable and oral FluCide drugs are estimated to require very large quantities of the drugs, because of strong safety data evidenced from our in vivo (animal) efficacy studies to date. The Company will be able to initiate GLP Safety/Toxicology studies ("Tox Package") studies of our injectable FluCide drug when the requisite large amount of drug substance is produced.

source: http://www.marketwatch.com/story/nanoviricides-reports-on-construction-progress-of-its-new-facility-and-cgmp-pilot-production-plant-2013-08-19

Can you explain the contradiction? Are you saying that although they did start production, they are unable to finish without certain key equipment pieces?